Forian Inc
NASDAQ:FORA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cathay Financial Holding Co Ltd
TWSE:2882
|
TW |
|
A
|
Afrimat Ltd
JSE:AFT
|
ZA |
|
Sivers Semiconductors AB
STO:SIVE
|
SE |
|
Cascades Inc
TSX:CAS
|
CA |
|
M
|
Myriad Genetics Inc
XHAM:MYD
|
US |
|
HWGG Entertainment Ltd
OTC:HWGG
|
MY |
|
Fosun International Ltd
HKEX:656
|
CN |
|
Semba Corp
TSE:6540
|
JP |
|
Mahanagar Gas Ltd
NSE:MGL
|
IN |
|
Lindab International AB
LSE:0MWK
|
SE |
|
Steppe Gold Ltd
TSX:STGO
|
MN |
Forian Inc
Goodwill
Forian Inc
Goodwill Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Goodwill | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Forian Inc
NASDAQ:FORA
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Goodwill
$439.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
16%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Goodwill
$67.9m
|
CAGR 3-Years
53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Goodwill
$737.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Goodwill
$4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Forian Inc
Glance View
Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The company is headquartered in Newtown, Pennsylvania and currently employs 138 full-time employees. The company went IPO on 2021-03-03. The firm provides software solutions, data and predictive analytics to optimize the operational, clinical and financial performance of its healthcare, cannabis, and government customers. Its BioTrack vertically integrated point-of-sale, manufacturing, delivery and cultivator software solution is a commercial platform in the cannabis industry, serving dispensaries, cultivators, manufacturers and distributors within 38 states and Puerto Rico. Its Cannalytics software as a service (SaaS)-based analytics solution is a platform that provides clients with a configurable and flexible presentation of business performance. Its real world experience (RWE) solutions are designed to enable the integration otherwise unconnected and disparate data to enable near real-time surveillance of adverse events and to study the clinical economic and social impacts of various therapeutic alternatives, including those derived from cannabinoids and psychedelics.